The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Items 301–400 of 1,001
17α-Estradiol prevents ovariectomy-mediated obesity and bone loss
Mann, S. N., Pitel, K. S., Nelson-Holte, M. H., Iwaniec, U. T., Turner, R. T., Sathiaseelan, R., Kirkland, J. L., Schneider, A., Morris, K. T., Subramaniam, M., et al. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111113 · Cited by 49
“Not only does menopause adversely affect bone homeostasis, it also promotes an increase in overall body fat and central adiposity (Carr, 2003; Christensen and Pike, 2015).”
InfluentialEffect of menopausal hormone therapy on components of the metabolic syndrome
Lovre, D., Lindsey, S. H., & Mauvais-Jarvis, F. (2017) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944716649358 · Cited by 44
“However, the menopausal transition itself is characterized by changes in body composition and metabolic homeostasis that predispose to MetS [Carr, 2003].”
BackgroundMenopause and Metabolic Syndrome in Tunisian Women
Ali, S. B., Belfki, H., Skhiri, H. A., Traissac, P., Maire, B., Delpeuch, F., Achour, N., & Romdhane, H. B. (2014) · BioMed Research International · doi:10.1155/2014/457131 · Cited by 47
“Menopause with its incidental hormonal changes appears to increase the risk of CVD independently of normal aging, and premenopausal women may be protected against CVD comparedwithmen and postmenopausal women of a similar age [8].”
BackgroundResultInfluentialMetabolic syndrome and menopause: A population-based study
Ebrahimpour, P., Fakhrzadeh, H., Heshmat, R., Ghodsi, M., Bandarian, F., & Larijani, B. A. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.014 · Cited by 46
Hypertension in the Metabolic Syndrome
Franklin, S. S. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.287 · Cited by 49
Goh, L. G. H., Dhaliwal, S. S., Welborn, T. A., Lee, A. H., & Della, P. R. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004702 · Cited by 49
“Menopausal status, which is associated with increased central obesity, has not been assessed in our study and has not been incorporated into these risk score models.(45) Further, the CVD risk was estimated using risk score models in order to stratify individuals above and below the respective treatment thresholds and…”
MethodSrimani, S., Saha, I., & Chaudhuri, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188331 · Cited by 44
Therapeutic strategies for type 2 diabetes mellitus in women after menopause
Paschou, S. Α., Marina, L., Spartalis, E. D., Anagnostis, P. G., Alexandrou, A. P., Goulis, D. G., & Lambrinoudaki, I. V. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.05.003 · Cited by 49
The Interaction of Insulin and Pituitary Hormone Syndromes
Schernthaner-Reiter, M. H., Wolf, P. S., Vila, G., & Luger, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626427 · Cited by 46
Kim, H. I., Ahn, S. H., Kim, Y., Lee, J. E., Choi, E., & Seo, S. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-17451-1 · Cited by 48
Centrally located body fat is related to inflammatory markers in healthy postmenopausal women
Perry, C. D., Alekel, D. L., Ritland, L., Bhupathiraju, S. N., Stewart, J. W., Hanson, L. N., Matvienko, O. A., Kohut, M. L., Reddy, M. B., Loan, M. D. V., et al. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318159f1a2 · Cited by 51
“region(2); correspondingly, estrogen deficiency in postmenopausal women plays a role in increasing centrally deposited fat.(3) This increase in centrally located fat is associated with greater disease risk than overall body fat, including metabolic syndrome, nonYinsulin-dependent diabetes,(4) heart disease,(5,6) and s…”
BackgroundPrasannarong, M., Vichaiwong, K., & Saengsirisuwan, V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.018 · Cited by 45
“In women, the systemic loss of ovarian function at menopause is associated with an increase in the amount of visceral fat [2,3], a higher prevalence of atherogenic lipid profiles, insulin resistance and type 2 diabetes [4,5].”
BackgroundGuinan, E. M., Connolly, E. M., Healy, L., Carroll, P. A., Kennedy, M. J., & Hussey, J. M. (2013) · Cancer Nursing · doi:10.1097/ncc.0b013e3182a40e6d · Cited by 46
“Insulin resistance is rarely observed in premenopausal women but emerges with the onset of menopause because of estrogen deficiency.(39) In a longitudinal analysis, Poehlman and colleagues(40) reported an increase of 11 (9) pmol/L in fasting insulin in 18 healthy premenopausal women who traversed menopause.”
BackgroundPredictors of serum polychlorinated biphenyl concentrations in Anniston residents
Pavúk, M., Olson, J. R., Wattigney, W. A., Dutton, N. D., Sjödin, A., Shelton, C., Turner, W. E., Bartell, S. M., Bartell, S. M., Carpenter, D. O., et al. (2014) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2014.06.113 · Cited by 43
“A contributing factor for this interaction may have been menopause, which has been found to be associated with a variety of metabolic changes and increased prevalence of metabolic syndrome (Carr, 2003; Lovejoy et al., 2008; Abildgaard et al., 2013).”
Soriguer, F., Morcillo, S., Hernando, V., Valdés, S., de Adana, M. S. R., Olveira, G., García‐Fuentes, E., González, I., Tapia, M. J., Esteva, I., et al. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31819d4113 · Cited by 43
Tørris, C., Molin, M., & Cvancarova, M. S. (2016) · BMC Public Health · doi:10.1186/s12889-016-3014-0 · Cited by 47
“Previously, both parity and an increasing number of children have been associated with higher risk of having MetS [7], and especially an increased central obesity have been observed in the transition from pre- to post menopause in women [8].”
BackgroundNakanishi, K., Nishida, M., Harada, M., Ohama, T., Kawada, N., Murakami, M., Moriyama, T., & Yamauchi‐Takihara, K. (2015) · Scientific Reports · doi:10.1038/srep14230 · Cited by 44
Metabolic and hormone influences on emotion processing during menopause
Berent‐Spillson, A., Marsh, C. A., Persad, C. C., Randolph, J. F., Zubieta, J., & Smith, Y. R. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.026 · Cited by 47
Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy
Kangas, R., Törmäkangas, T., Fey, V., Pursiheimo, J., Miinalainen, I., Alén, M., Kaprio, J. A., Sipilä, S., Säämänen, A., Kovanen, V., et al. (2017) · Scientific Reports · doi:10.1038/srep42702 · Cited by 47
Steckling, F. M., Farinha, J. B., Figueiredo, F. D. C., Santos, D. L. D., Bresciani, G., Kretzmann, N. A., Stefanello, S. T., Courtes, A. A., Beck, M. D. O., Sangoi Cardoso, M., et al. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1437750 · Cited by 41
“Altogether, these events may contribute to increased oxidative stress, endothelial dysfunction, changes in lipid profile, and increased systemic inflammation in this population (Carr 2003, Tiidus 2003).”
BackgroundDelgobo, M., Agnes, J. P., Gonçalves, R. M., dos Santos, V. W., Parisotto, E. B., Zamoner, A., & Zanotto‐Filho, A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.02.012 · Cited by 49
Lei, Z., Wu, H., Yang, Y., Hu, Q. C., Lei, Y., Liu, W., Nie, Y., Yang, L., Zhang, X., Yang, C., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.708838 · Cited by 46
Wang, M., Gan, W., Kartsonaki, C., Yu, C., Lv, J., Chen, Z., Li, L., Yang, L., & Yu, M. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00643-x · Cited by 43
Jaff, N. G., Norris, S. A., Snyman, T., Toman, M., & Crowther, N. J. (2015) · Metabolism · doi:10.1016/j.metabol.2015.05.009 · Cited by 47
“A multi-ethnic cross-sectional survey found, after adjusting for age, that women with natural menopause did not have increased BMI compared to premenopausal women [28], and some longitudinal studies found no difference in BMI between pre- and postmenopausal women, although differences in BFD with reproductive aging we…”
BackgroundResultKim, M. K., Ahn, C. W., Nam, J. S., Kang, S., Park, J. S., & Kim, K. R. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000503 · Cited by 43
Windler, E. E. T., Schoeffauer, M., & Zyriax, B. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.032 · Cited by 51
Nguyen, H. D., & Kim, M. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001825 · Cited by 42
“MetS occurs in many women with estrogen deficiency.(31)”
BackgroundPark, Y. M., Kanaley, J. A., Padilla, J., Zidon, T. M., Welly, R. J., Will, M. J., Britton, S. L., Koch, L. G., Ruegsegger, G. N., Booth, F. W., et al. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.06.006 · Cited by 45
“major psychological/molecular pathway involved in menopause-associated physical inactivity in order to attenuate the CVD-related consequences of menopause, a vicious circle driven by both menopause [5] and consequent physical inactivity [2, 6].”
Kazlauskaite, R., Janssen, İ., Wilson, R. S., Appelhans, B. M., Evans, D. A., Arvanitakis, Z., Khoudary, S. R. E., & Kravitz, H. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa067 · Cited by 47
van Dijk, G. M., Maneva, M., Colpani, V., Dhana, K., Muka, T., Jaspers, L., Kavousi, M., & Franco, O. H. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.11.016 · Cited by 42
Energy balance modulates colon tumor growth: Interactive roles of insulin and estrogen
Rondini, E. A., Harvey, A. E., Steibel, J. P., Hursting, S. D., & Fenton, J. I. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20720 · Cited by 42
“Inhumans, the decline in circulating sex hormones during menopause is associatedwith an increase invisceral fat and a higher prevalence of insulin resistance and type 2 diabetes [28,29].”
BackgroundEctopic lipid deposition and the metabolic profile of skeletal muscle in ovariectomized mice
Jackson, K. C., Wohlers, L. M., Lovering, R. M., Schuh, R. A., Maher, A. C., Bonen, A., Koves, T. R., Ilkayeva, O., Thomson, D. M., Muoio, D. M., et al. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00428.2012 · Cited by 42
“Previous publications have shown that the surgical removal of ovaries or the onset of ovarian failure in women leads to adiposity, particularly in the visceral region, which corresponds with glucose intolerance and insulin resistance (8).”
BackgroundLife-Course Socioeconomic Status and Metabolic Syndrome Among Midlife Women
Montez, J. K., Bromberger, J. T., Harlow, S. D., Kravitz, H. M., & Matthews, K. A. (2016) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbw014 · Cited by 49
“For instance, the effect may strengthen with age as the prevalence of MetS among women increases after menopause (Carr, 2003) or decline as the proportion of life spent in childhood shrinks.”
BackgroundKhan, I., Kwon, M., Shivappa, N., Hébert, J. R., & Kim, M. K. (2020) · Nutrients · doi:10.3390/nu12041196 · Cited by 42
“This increased impact can be explained by the fact that the women after menopause lack estrogen hormone, which help to alter fat metabolism and, as a result, this promote MetS [42].”
BackgroundFernandez, M., & Murillo, A. (2016) · Healthcare · doi:10.3390/healthcare4010020 · Cited by 37
“This augmented visceral adipose tissue (VAT) is positively associated with cardiovascular risk factors and metabolic diseases [12,13] and it is considered one of the components of the metabolic syndrome (MetS) [14].”
BackgroundResultInfluentialAge, gender and metabolic syndrome-related coronary heart disease in U.S. adults
Tong, W., Lai, H. C., Yang, C., Ren, S., Dai, S., & Lai, S. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.035 · Cited by 46
Sivasinprasasn, S., Sa‐nguanmoo, P., Pratchayasakul, W., Kumfu, S., Chattipakorn, S. C., & Chattipakorn, N. (2015) · AGE · doi:10.1007/s11357-015-9766-0 · Cited by 40
“A bilateral ovariectomy (OVX) in women has also been shown to be associated with increased mortality from CVDs (Rivera et al. 2009), which may be due to the fact that estrogen is essentially involved in the regulation of cardiac function.”
BackgroundInfluentialPhysical Activity and Body Mass: Changes in Younger versus Older Postmenopausal Women
Sims, S. T., Larson, J. C., LaMonte, M. J., Michael, Y. L., Martin, L. W., Johnson, K., Sarto, G. E., & Stefanick, M. L. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318227f906 · Cited by 48
Hirose, A., Terauchi, M., Akiyoshi, M., Owa, Y., Kato, K., & Kubota, T. (2016) · BioPsychoSocial Medicine · doi:10.1186/s13030-016-0066-4 · Cited by 42
Park, Y.-M., Pereira, R. I., Erickson, C. B., Swibas, T., Cox‐York, K. A., & Pelt, R. E. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176446 · Cited by 45
Zając-Gawlak, I., Pelclová, J., Groffik, D., Přidalová, M., Nawrat–Szołtysik, A., Kroemeke, A., Gába, A., & Sadowska‐Krępa, E. (2021) · BMC Geriatrics · doi:10.1186/s12877-020-01952-7 · Cited by 39
Corrigan, E. C., Nelson, L. M., Bakalov, V. K., Yanovski, J. A., Vanderhoof, V. H., Yanoff, L. B., & Bondy, C. A. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000248702.25259.00 · Cited by 39
Andersson, T., Simonyte, K., Andrew, R., Strand, M., Burén, J., Walker, B. R., Mattsson, C., & Olsson, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008475 · Cited by 37
“Abdominal fat accumulation, and menopause per se, links to an increased risk of insulin resistance, type 2 diabetes, and future cardiovascular disease [3,4].”
BackgroundLee, B.-A., & Oh, D.-J. (2015) · Journal of Exercise Rehabilitation · doi:10.12965/jer.150242 · Cited by 42
“Abdominal fat due to the increase in body fat causes visceral fat, and the increase in this visceral fat is said to be the risk factor that causes many diseases such as metabolic diseases, cardiac disorders, and arthritis (Carr, 2003).”
BackgroundWilliams, L. T., Hollis, J., Collins, C. E., & Morgan, P. J. (2014) · Nutrition and Diabetes · doi:10.1038/nutd.2014.12 · Cited by 38
Bless, E. P., Yang, J., Acharya, K. D., Nettles, S. A., Vassoler, F. M., Byrnes, E. M., & Tetel, M. J. (2016) · eNeuro · doi:10.1523/eneuro.0027-16.2016 · Cited by 41
“For example, postmenopausal women gain fat weight, which increases their risk for heart disease and type 2 diabetes (Guo et al., 1999; Carr, 2003).”
BackgroundChristensen, A., & Pike, C. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178490 · Cited by 39
González‐Rodríguez, M., Pazos-Couselo, M., López, J. M. G., Rodríguez‐Segade, S., Rodríguez, J., Túñez-Bastida, C., & Gudé, F. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0368-1 · Cited by 44
“Women and men of similar age have no differences in insulin sensitivity but after menopause there is a decline in insulin sensitivity and an increase in fat mass [32].”
BackgroundNguyen, H. D., Oh, H., & Kim, M. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001865 · Cited by 38
Impact of hormone therapy for women aged 35 to 65 years, from contraception to hormone replacement
KASE, N. G. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.001 · Cited by 43
Andersson, T., Söderström, I., Šimonytė, K., & Olsson, T. (2010) · Obesity · doi:10.1038/oby.2009.294 · Cited by 41
“Furthermore, there is an increase in intra-abdominal adipose tissue linked to insulin resistance and increased risk of cardiovascular disease in postmenopausal women (1,2).”
BackgroundMenopause, lung function and obstructive lung disease outcomes: a systematic review
Campbell, B., Davis, S. R., Abramson, M. J., Mishra, G. D., Handelsman, D. J., Perret, J. L., & Dharmage, S. C. (2017) · Climacteric · doi:10.1080/13697137.2017.1392504 · Cited by 40
Saltiki, K., & Alevizaki, M. K. (2007) · PubMed · Cited by 47
Regulation of Energy Balance via BDNF Expressed in Nonparaventricular Hypothalamic Neurons
Yang, H., An, J. J., Sun, C., & Xu, B. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1329 · Cited by 37
Lifelong exposure to dietary isoflavones reduces risk of obesity in ovariectomized Wistar rats
Kurrat, A., Blei, T., Kluxen, F. M., Mueller, D. R., Piechotta, M., Soukup, S. T., Kulling, S. E., & Diel, P. R. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500240 · Cited by 40
“Especially in postmenopausal women obesity is triggered by the loss of circulating estrogens, which is mostly accompanied by an unfavorable change in body composition with a loss of muscle mass and an increase of abdominal fat [6].”
BackgroundMuñoz, M. J. F., Acevedo, L. B., Pérez, N. C., Martinez, A. L., Gutiérrez, N. T., Vega-García, S., Cruz, A. R., Martínez, A. D., García, R. S., Treviño, A. Z., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.10.013 · Cited by 41
Choi, J. Y., Ha, H. S., Kwon, H., Lee, S., Cho, H., Yim, H. W., Lee, W., & Park, Y. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31825d26b6 · Cited by 39
“Subsequently, clinical and biochemical variables were added to the other model to evaluate the coexisting metabolic risk factors for CVD.”
BackgroundInfluentialNaito, R., & Imafuku, S. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13439 · Cited by 37
Nonnuclear Estrogen Receptor Activation Improves Hepatic Steatosis in Female Mice
Chambliss, K. L., Barrera, J., Umetani, M., Umetani, J., Kim, S. H., Madak-Erdogan, Z., Huang, L., Katzenellenbogen, B. S., Katzenellenbogen, J. A., Mineo, C., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1629 · Cited by 35
Estradiol Regulation of Brown Adipose Tissue Thermogenesis
González‐García, I., Tena‐Sempere, M., & López, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_15 · Cited by 39
Porter, J. W., Barnas, J., Welly, R. J., Spencer, N., Pitt, J., Vieira‐Potter, V. J., & Kanaley, J. A. (2020) · Obesity · doi:10.1002/oby.22888 · Cited by 38
Ward‐Ritacco, C. L., Adrian, A. L., Johnson, M. A., Rogers, L. Q., & Evans, E. M. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000225 · Cited by 43
Differences in the fatty acid metabolism of visceral adipose tissue in postmenopausal women
Yamatani, H., Takahashi, K., Yoshida, T., Soga, T., & Kurachi, H. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318296431a · Cited by 37
The role of estrogens in cardiovascular disease in the aftermath of clinical trials
Gouva, L., & Tsatsoulis, A. A. (2004) · HORMONES · doi:10.14310/horm.2002.11124 · Cited by 45
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 39
“Lower levels of estrogens in postmenopausal women [528] or in ovariectomized animals are associated with obesity [529], while estradiol-17β replacement in ovariectomized mice prevents weight gain by diminishing food intake and stimulating energy expenditure [529].”
BackgroundProgesterone increases skeletal muscle mitochondrial H2O2emission in nonmenopausal women
Kane, D. A., Lin, C.-T., Anderson, E. J., Kwak, H.-B., Cox, J. H., Brophy, P. M., Hickner, R. C., Neufer, P. D., & Cortright, R. N. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00389.2010 · Cited by 36
The adrenal gland may be a target of LH action in postmenopausal women
Alevizaki, M. K., Saltiki, K., Mantzou, A., Anastasiou, E., & Huhtaniemi, I. T. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02165 · Cited by 41
“DHEA-S stimulating effect of LH in adrenal glands can contribute to the increased frequency of the metabolic syndrome in peri- and postmenopausal women ( 35 ).”
BackgroundLapointe, A., Couillard, C., Piché, M., Weisnagel, S. J., Bergeron, J., Nadeau, A., & Lemieux, S. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.036 · Cited by 37
“Accordingly, postmenopausal status is associted with a higher triglyceride (TG) concentration [2] as ell as a lower concentration of high-density lipoprotein holesterol (HDL-C) [3].”
BackgroundVisceral adiposity indicators as predictors of metabolic syndrome in postmenopausal women
İlhan, G. A., & Yıldızhan, B. (2019) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2019.62558 · Cited by 38
“Modern lifestyle changes, decreased physical activities, and concomitant increase in obesity subsequently result in a rise in the prevalence of MetS, a condition that affects the morbidity and mortality of older women, with an increased risk for CVD and T2DM(11,19).”
BackgroundInfluentialMenopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review
Paschou, S. Α., Athanasiadou, K. I., & Παπάνας, Ν. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01546-1 · Cited by 40
“Metabolic syndrome has a high prevalence in postmenopausal women, indicating the loss of the favorable estrogen effects [12].”
BackgroundHealth of adipose tissue: oestrogen matters
Vieira‐Potter, V. J., Mishra, G., & Townsend, K. L. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01180-2 · Cited by 36
“Menopausal women are known to be at higher risk of metabolic disease than premenopausal women and age-matched men 17,18 , yet less is known about the metabolic risks associated with the perimenopausal period, characterized by wide hormone fluctuations that precede menopause.”
Commuting physical activity and prevalence of metabolic disorders in Poland
Kwaśniewska, M., Kaczmarczyk-Chałas, K., Pikala, M., Broda, G., Kozakiewicz, K., Pająk, A., Tykarski, A., Zdrojewski, T. R., & Drygas, W. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.09.003 · Cited by 38
Cross-talk between metabolism and reproduction: the role of POMC and SF1 neurons
Xu, Y., Faulkner, L. D., & Hill, J. W. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00098 · Cited by 38
“Besides being a reproductive cue, estrogens also exert important anti-obesity effects in women (Flegal et al., 2002; Freedman et al., 2002; Carr, 2003) and female mammals (Drewett, 1973; Blaustein and Wade, 1976; Wallen et al.”
BackgroundLuque, R. M., Lopez-Sanchez, L. M., Villa-Osaba, A., Luque, I. M., Santos-Romero, A. L., Yubero‐Serrano, E. M., García, M. C., Benito, M. Á., López‐Miranda, J., Gahete, M. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20399 · Cited by 36
“This observation could be associated to the fact that postmenopausal woman already exhibit impaired glucose/insulin metabolism compared to premenopausal women ([30, 31] and data presented herein).”
ResultBobescu, E., Bălan, A., Moga, M., Teodorescu, A., Mitrică, M., & Dima, L. (2020) · Marine Drugs · doi:10.3390/md18120651 · Cited by 37
“According to these findings, estrogen deficiency enhances metabolic abnormalities, leading to diabetes mellitus type 2, metabolic syndrome and other cardiovascular events [23].”
BackgroundDieli-Conwright, C. M., Wong, L. C., Waliany, S., & Mortimer, J. E. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00807-y · Cited by 36
“Notably, women without a breast cancer diagnosis experience heightened risks of MetS and cardiovascular disease (CVD) particularly during the menopausal transition, which typically occurs in early to mid-50 years of age [24].”
BackgroundOne-year soy protein supplementation does not improve lipid profile in postmenopausal women
Campbell, S. C., Khalil, D. A., Payton, M. E., & Arjmandi, B. H. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181cb85d3 · Cited by 36
Social Disadvantage, Severe Child Abuse, and Biological Profiles in Adulthood
Lee, C., Coe, C. L., & Ryff, C. D. (2017) · Journal of Health and Social Behavior · doi:10.1177/0022146516685370 · Cited by 40
Hirose, A., Terauchi, M., Osaka, Y., Akiyoshi, M., Kato, K., & Miyasaka, N. (2018) · Nutrition Journal · doi:10.1186/s12937-018-0314-5 · Cited by 39
Barbat-Artigas, S., Filion, M.-E., Plouffe, S., & Aubertin-Leheudre, M. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0092 · Cited by 35
“Obesity has been widely recognized as a predisposing factor to cardiovascular diseases (CVD) and the metabolic syndrome, particularly among postmenopausal women, mainly due to the changes in body composition associated with menopause.(1) It is interesting to note that two subgroups of obese individuals appear to devia…”
Estrogen and exercise may be related to body fat distribution and leptin in young women
Puder, J. J., Monaco, S. E., Gupta, S. S., Wang, J., Ferin, M., & Warren, M. P. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.085 · Cited by 36
“Cross-sectional data demonstrated an inrease in central obesity in postmenopausal women when ompared with premenopausal women (7, 10), even after djustment for total body fat (33), age (8), or both (9).”
Association between metabolic syndrome and serum leptin levels in postmenopausal women
Lee, S. W., Jo, H., Kim, J.-H., You, Y. O., & Kim, J. H. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.618893 · Cited by 39
“Th e increase in prevalence in MetS in postmenopausal women may increase the risk of CVD; therefore, the prevention and treatment of MetS are important.”
BackgroundInfluentialBuniam, J., Chukijrungroat, N., Rattanavichit, Y., Surapongchai, J., Weerachayaphorn, J., Bupha-Intr, T., & Saengsirisuwan, V. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02936-1 · Cited by 35
Pharmacotherapy for schizophrenia in postmenopausal women
González-Rodríguez, A., & Seeman, M. V. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1465563 · Cited by 35
Rajendran, R., Abu, E. O., Fadl, A. A., & Byrne, C. D. (2013) · Diabetic Medicine · doi:10.1111/dme.12234 · Cited by 35
Early Menopause in Type 2 Diabetes – A Study from a South Indian Tertiary Care Centre
Medarametla, S. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/14181.6628 · Cited by 43
“The occurrence of dysglycemia may be a direct result of the ovarian failure, or alternatively an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency [17].”
BackgroundMetabolic syndrome among rural Indian adults
Barik, A., Das, K., Chowdhury, A., & Kumar, R. (2017) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2017.11.002 · Cited by 39
Hormone Replacement Therapy and Cardioprotection: The End of the Tale?
Rosano, G. M. C., Vitale, C., Silvestri, A., & Fini, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.038 · Cited by 35
Beyond reproduction: unraveling the impact of sex hormones on cardiometabolic health
Xega, V., & Liu, J. (2024) · Medical Review · doi:10.1515/mr-2024-0012 · Cited by 35
Liao, C.-C., Chiu, Y., Chiu, W., Tung, Y., Chuang, H.-L., Wu, J., & Huang, C. (2015) · Nutrients · doi:10.3390/nu7105434 · Cited by 36
“The prevalence of NAFLD increases with age, obesity, and postmenopausal status [2].”
BackgroundRogers, N. H., Perfield, J. W., Strissel, K. J., Obin, M. S., & Greenberg, A. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.072 · Cited by 30
“Menopause promotes increased visceral adiposity and type 2 diabetes [1], but mechanisms remain unclear.”
BackgroundDehghan, A., Vasan, S. K., Fielding, B. A., & Karpe, F. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001721 · Cited by 34
“The menopause is also known to be associated with increases in total fat mass and changes in body fat distribution toward a more android phenotype.(10) The majority of evidence to support these fat distribution changes come from cross sectional studies comparing premenopausal to postmenopausal women using dual energy…”
BackgroundPredictors for metabolic syndrome in perimenopausal and postmenopausal Thai women
Indhavivadhana, S., Rattanachaiyanont, M., Wongvananurak, T., Kanboon, M., Techatraisak, K., Leerasiri, P., Tanmahasamut, P., & Angsuwathana, S. (2011) · Climacteric · doi:10.3109/13697137.2010.481735 · Cited by 36
Over expression of resistin in adipose tissue of the obese induces insulin resistance
Sadashiv, Tiwari, S., Paul, B. N., Kumar, S., Chandra, A., Dhananjai, S., & Negi, M. P. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i7.135 · Cited by 38
Drospirenone, a New Progestogen, for Postmenopausal Women with Hypertension
Mallareddy, M., Hanes, V., & White, W. B. (2007) · Drugs & Aging · doi:10.2165/00002512-200724060-00002 · Cited by 34
Resistance training prevents liver fat accumulation in ovariectomized rats
Corriveau, P., Paquette, A., Brochu, M., Prud’homme, D., RABASA-LHORET, R. P. R., & Lavoie, J.-M. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.02.005 · Cited by 39
“The prevalence of insulin resistance and dysipidemia increases with age, obesity (especially bdominal obesity), and menopause and are associted with increased risks of cardiovascular diseases n women [1].”
BackgroundLandis, C. A., & Moe, K. E. (2004) · Nursing Clinics of North America · doi:10.1016/j.cnur.2003.11.006 · Cited by 38
Síndrome metabólica em hipertensos de Cuiabá - MT: prevalência e fatores associados
Franco, G. P. P., Scala, L. C. N., Alves, C. J., de França, G. V. A., Cassanelli, T., & Jardim, P. C. B. V. (2009) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2009000600010 · Cited by 32
de Oliveira, M. C., Campos-Shimada, L. B., Natali, M. R. M., Ishii‐Iwamoto, E. L., & Salgueiro‐Pagadigorria, C. L. (2018) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0038-1666856 · Cited by 35
“32 A reduced production of acetyl-CoA derived from octanoate oxidation seems to be, thus, the most plausible explanation for the decrease in both ketogenesis and 14 CO 2 production from [1-14 C]octanoate in perfused livers.”
Luís, Â., Domingues, F., & Pereira, L. C. (2018) · Climacteric · doi:10.1080/13697137.2018.1501673 · Cited by 32
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.